
United States · Medical Device startup
BioImagene offers tissue-based integrated hardware and software solutions for clinical diagnostics and drug discovery applications.
Funding reportedLast round: Series D
Follow BioImagene and see its new rounds in your feed.Start following
Funding, as reported
From the SEC filings it signed: 4 on the team.
On the board, as filediG. Steven BurrillJoseph KeeganMatthew HermannYatin Mundkur
Exit
Add your raise, your deck and your story, and put BioImagene in front of investors. Or tell us what we have wrong.